Vipergen

Vipergen is a global leading provider of small molecule drug discovery services based on DNA-encoded library (DEL) technology. Vipergen offers different business models, including the straightforward "pay-per-service" model. Vipergen ApS owns the first technology for screening internally DNA-encoded small molecule libraries (DEL), and this proprietary technology will significantly accelerate and enhance the drug discovery process.